Septerna Share Price Today
(NASDAQ: SEPN)

Name: Septerna Share Price Today (NASDAQ: SEPN) - Septerna Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Septerna share price is $5.93 & ₹515.73 as on 6 Mar 2025, 2.30 'hrs' IST

$5.93

▲

-0.23

(-3.73%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Septerna share price in Dollar and Rupees. Guide to invest in Septerna stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Septerna, along with analyst recommendations, forecasts, and comprehensive financials.

Septerna share price movements

Today's Low: $5.67
Today's High: $6.43
$5.93
4.38%
Downside
Day's Volatility :11.82%
Upside
7.78%
52 Weeks Low: $4.17
52 Weeks High: $28.99
$5.93
29.68%
Downside
52 Weeks Volatility :85.62%
Upside
79.54%

Septerna (SEPN) Returns

Period	Septerna Inc.	Index (Russel 2000)
3 Months	-75.55%	0.0%
6 Months	-71.21%	0.0%
1 Year	-71.21%	0.0%
3 Years	-71.21%	-11.6%

Septerna (SEPN) Key Statistics

in dollars & INR

Previous Close	$6.16
Open	$6.21
Today's High	$6.43
Today's Low	$5.67
Today's Volume	$178.8K
52 Week High	$28.99
52 Week Low	$4.17
Revenue TTM	$0.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Septerna Stock (SEPN) from India?

It is very easy for Indian residents to invest directly in Septerna from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Septerna stock in both Indian Rupees (INR) and US Dollars (USD). Search for Septerna or SEPN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Septerna or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Septerna shares which would translate to 0.147 fractional shares of Septerna as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Septerna, in just a few clicks!

Returns in Septerna (SEPN) for Indian investors in Rupees

The Septerna stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Septerna investment value today

Current value as on today

₹32,673

Returns

₹67,327

(-67.33%)

Returns from Septerna Stock

₹72,290 (-72.29%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Septerna (SEPN)

20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Septerna Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Septerna

Insights on Septerna Stock (Ticker Symbol: SEPN)

Price Movement
In the last 7 days, SEPN stock has moved up by 8.1%

Septerna Technicals Summary

Sell

Neutral

Buy

Septerna is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Septerna (SEPN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Septerna Inc.	-60.54%	-71.21%	-71.21%	-71.21%	-71.21%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Septerna Inc.	NA	NA	NA	0.0	0.0	0.0	NA	NA
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Septerna Inc.	NA	NA	-71.21%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Septerna

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.

Organization	Septerna
Employees	73
CEO	Dr. Jeffrey T. Finer M.D., Ph.D.
Industry	Miscellaneous

Management People of Septerna

Name	Title
Dr. Jeffrey T. Finer M.D., Ph.D.	Co-Founder, CEO, President & Director
Ms. Elizabeth P. Bhatt M.B.A., M.S.	Chief Operating Officer
Ms. Samira Shaikhly	Chief People Officer
Dr. Daniel Long DPHIL	Senior Vice President of Drug Discovery
Mr. Uwe Klein Ph.D.	Senior Vice President of Biological Sciences
Dr. Robert J. Lefkowitz M.D.	Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
Dr. Arthur Christopoulos BPHARM, Ph.D.	Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
Dr. Patrick Sexton Ph.D.	Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
Mr. Gilbert M. Labrucherie C.F.A., J.D.	Chief Financial Officer
Mr. Richard Hansen Ph.D.	Vice President of Technology

Important FAQs about investing in SEPN Stock from India :

What is Septerna share price today?

Septerna share price today stands at $5.93, Open: $6.21 ; Previous Close: $6.16 ; High: $6.43 ; Low: $5.67 ; 52 Week High: $28.99 ; 52 Week Low: $4.17.

The stock opens at $6.21, after a previous close of $6.16. The stock reached a daily high of $6.43 and a low of $5.67, with a 52-week high of $28.99 and a 52-week low of $4.17.

Can Indians buy Septerna shares?

Yes, Indians can invest in the Septerna (SEPN) from India.

With INDmoney, you can buy Septerna at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Septerna at zero transaction cost.

How can I buy Septerna shares from India?

It is very easy to buy Septerna from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Septerna (SEPN) be purchased?

Yes, you can buy fractional shares of Septerna with INDmoney app.

What are the documents required to start investing in Septerna stocks?

To start investing in Septerna, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.